Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide

This publication has 59 references indexed in Scilit:

• Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
  The Lancet, 1998
• Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia
  Leukemia, 1997
• Effects of cytosine arabinoside on human leukemia cells
  The International Journal of Biochemistry & Cell Biology, 1996
• Exposure and schedule dependency of etoposide in neuroblastoma and leukaemia cells in vitro
  European Journal Of Cancer, 1995
• Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
  Medical and Pediatric Oncology, 1991
• Pharmacokinetic Studies of Intermediate- to High-Dose 1-β-D-Arabinofuranosylcytosine in Children With Acute Leukemia and Lymphoma
  The Journal of Clinical Pharmacology, 1987
• Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic Leukemia
  New England Journal of Medicine, 1986
• Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
  Journal of Clinical Investigation, 1985
• THE COMPARATIVE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON TRANSPLANTED HEMATOPOIETIC CELLS
  Transplantation, 1972
• Cyclophosphamide in the treatment of common neoplastic diseases of childhood
  The Journal of Pediatrics, 1962